| 2024-02-14 | Sale | Merck & Co., Inc. MRK | Chairman, CEO & President | 85,021 0.0034% | $125.40 | $10.66M | +1.78% | |
| 2024-02-13 | Sale | Merck & Co., Inc. MRK | Chairman, CEO & President | 150,000 0.0059% | $125.85 | $18.88M | +2.04% | |
| 2023-04-28 | Sale | Merck & Co., Inc. MRK | Chairman, CEO & President | 143,329 0.0056% | $114.93 | $16.47M | -4.38% | |
| 2022-11-09 | Sale | Merck & Co., Inc. MRK | CEO & President | 167,613 0.0067% | $102.44 | $17.17M | +8.34% | |
| 2020-10-05 | Sale | Merck & Co., Inc. MRK | EVP, Global Svcs & CFO | 502,546 0.0166% | $67.85 | $34.1M | -1.14% | |
| 2019-06-25 | Sale | Merck & Co., Inc. MRK | EVP, Global Svcs & CFO | 433,436 0.0169% | $85.43 | $37.03M | -1.61% | |
| 2019-03-25 | Sale | Merck & Co., Inc. MRK | EVP, Global Svcs & CFO | 385,144 0.0127% | $70.30 | $27.07M | +2.48% | |
| 2013-05-17 | Sale | Baxter International Inc. BAX | Corporate Vice President | 261,600 0.0888% | $73.00 | $19.1M | -3% | |
| 2011-07-25 | Sale | Baxter International Inc. BAX | Corporate Vice President | 101,000 0.033% | $61.66 | $6.23M | -10.21% | |
| 2007-12-14 | Sale | Baxter International Inc. BAX | Corporate Vice President | 20,000 0.0059% | $58.77 | $1.18M | +5.84% |